FDA grants clearance to Gilead Sciences’ sNDA for Veklury
The US Food and Drug Administration (FDA) has granted clearance to Gilead Sciences’ supplemental new drug application (sNDA) for Veklury.
The US Food and Drug Administration (FDA) has granted clearance to Gilead Sciences’ supplemental new drug application (sNDA) for Veklury.
What's Your Reaction?
